Helping You Achieve Accuracy and Reliability in Infectious Disease Diagnostics
Discover the forefront of biological innovation with Microbix Biosystems Inc.
Since 1985, Microbix has been a recognized leader committed to advancing diagnostic precision through unparalleled expertise and advanced product offerings.
We offer a diverse range of proprietary biological and technological solutions to enhance infectious disease detection, improve understanding, and transform the future of global healthcare. Join us on a path to precision, reliability, and advancement, as we work together to redefine the standards of healthcare diagnostics, research, and development.
40+ Years in Business
280+ Customers
500+ Products in our Catalogue
30+ Countries Shipped To
Areas of Expertise
Trusted Diagnostic Solutions for Infectious Diseases
Propel your testing and research endeavors forward with our extensive portfolio of proprietary biological and technological diagnostic solutions.
Control Elution Buffer
Our Control Elution Buffer is a stable sample elution buffer for control swab formulations used in diagnostic tests. The product is commonly used as an intermediate step for preparing the control swab formulations in validation/verification protocols including the swab sample elution step.
Microbix offers aseptic custom filling services in a state-of-the-art facility across a range of fields to compliantly meet your needs on a pilot or commercial scale. The aseptic capabilities include two types of filling lines: 10,000 vials per day or 60,000 vials per day.
With one of the industry’s most extensive portfolios of infectious disease antigens, we provide the viral, bacterial, and parasitic products you need to support your diagnostic goals and deliver reliable results. Beyond diagnostics, our products are also instrumental in advancing research in fields like epidemiology, virology, and immunology.
Our Quality Assessment Products (QAPs™) are expertly designed to emulate patient samples using native pathogens or synthetic genomes. Trust in our ready-to-use solutions to enhance the precision and reliability of your diagnostic processes.
Our Control Elution Buffer is a stable sample elution buffer for control swab formulations used in diagnostic tests. The product is commonly used as an intermediate step for preparing the control swab formulations in validation/verification protocols including the swab sample elution step.
Microbix offers aseptic custom filling services in a state-of-the-art facility across a range of fields to compliantly meet your needs on a pilot or commercial scale. The aseptic capabilities include two types of filling lines: 10,000 vials per day or 60,000 vials per day.
With one of the industry’s most extensive portfolios of infectious disease antigens, we provide the viral, bacterial, and parasitic products you need to support your diagnostic goals and deliver reliable results. Beyond diagnostics, our products are also instrumental in advancing research in fields like epidemiology, virology, and immunology.
Our Quality Assessment Products (QAPs™) are expertly designed to emulate patient samples using native pathogens or synthetic genomes. Trust in our ready-to-use solutions to enhance the precision and reliability of your diagnostic processes.
Our Control Elution Buffer is a stable sample elution buffer for control swab formulations used in diagnostic tests. The product is commonly used as an intermediate step for preparing the control swab formulations in validation/verification protocols including the swab sample elution step.
Microbix offers aseptic custom filling services in a state-of-the-art facility across a range of fields to compliantly meet your needs on a pilot or commercial scale. The aseptic capabilities include two types of filling lines: 10,000 vials per day or 60,000 vials per day.
Diagnostic & Research Solutions for the Entire Healthcare Ecosystem
Microbix has a large portfolio of infectious disease antigens produced at commercial scale that serve as key ingredients for manufacturing diagnostic tests and external quality control materials. The antigens can also be used for vaccine R&D and applied research in microbiology, virology, cell biology, immunology, and pathology.
Vaginal Infection Quality Controls
Whole-workflow multi-analyte vaginal infection research use only (RUO) external quality controls are designed for nucleic acid amplification tests that detect the most common causes of vaginal infections, including bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis.
Gastrointestinal IVD Controls and RUO samples are available as single-analyte and multiplex liquid and swab formulations. The panel includes Cryptosporidium parvum, Giardia lamblia, Helicobacter pylori, C. difficile, Campylobacter, Rotavirus, and more.
Various ONBOARDx kits including RUO samples from our SARS-CoV-2, RESP and HPV EQC panels. Custom ONBOARDx™ kits to evaluate assay performance are also available.
Our respiratory antigens cover infections such as Adenovirus, RSV, Parainfluenza 2 & 3, Flu A & B, and Chlamydia pneumoniae for test innovation and development.
ToRCH infections include Toxoplasmosis, Other (Varicella Zoster virus), Syphilis, and Parvovirus B19), Cytomegalovirus, Rubella Virus, and Herpes Simplex Virus.
Respiratory Panel IVD controls and RUO samples are available as single-analyte and multiplex liquid and swab formulations. The panel covers SARS-CoV-2, RSV, Flu A & B, Parainfluenza viruses, Adenovirus, Group A Strep, and more.
Extensive high-risk HPV panel, covering HPV types 16, 18, 31, 33, 39, 45, 51, 52, and 66. HPV IVD Controls and RUO samples are available as single-analyte and multiplex liquid and swab formulations.
STI and RUO controls are available as single-analyte and multiplex liquid and swab formulations that cover Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonnorrhoeae, Mycoplasma genitalium (and antimicrobial resistant strains), HSV1 &2.
The genital ulcer panels are available as liquid and swab formulations of inactivated Herpes Simplex Virus type 1 and 2, Varicella Zoster Virus, Treponema pallidum, and Monkeypox Virus.
Whole-workflow multi-analyte vaginal infection research use only (RUO) external quality controls are designed for nucleic acid amplification tests that detect the most common causes of vaginal infections, including bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis.
Gastrointestinal IVD Controls and RUO samples are available as single-analyte and multiplex liquid and swab formulations. The panel includes Cryptosporidium parvum, Giardia lamblia, Helicobacter pylori, C. difficile, Campylobacter, Rotavirus, and more.
Various ONBOARDx kits including RUO samples from our SARS-CoV-2, RESP and HPV EQC panels. Custom ONBOARDx™ kits to evaluate assay performance are also available.
Our respiratory antigens cover infections such as Adenovirus, RSV, Parainfluenza 2 & 3, Flu A & B, and Chlamydia pneumoniae for test innovation and development.
ToRCH infections include Toxoplasmosis, Other (Varicella Zoster virus), Syphilis, and Parvovirus B19), Cytomegalovirus, Rubella Virus, and Herpes Simplex Virus.
Respiratory Panel IVD controls and RUO samples are available as single-analyte and multiplex liquid and swab formulations. The panel covers SARS-CoV-2, RSV, Flu A & B, Parainfluenza viruses, Adenovirus, Group A Strep, and more.
Extensive high-risk HPV panel, covering HPV types 16, 18, 31, 33, 39, 45, 51, 52, and 66. HPV IVD Controls and RUO samples are available as single-analyte and multiplex liquid and swab formulations.
STI and RUO controls are available as single-analyte and multiplex liquid and swab formulations that cover Trichomonas vaginalis, Chlamydia trachomatis, Neisseria gonnorrhoeae, Mycoplasma genitalium (and antimicrobial resistant strains), HSV1 &2.
The genital ulcer panels are available as liquid and swab formulations of inactivated Herpes Simplex Virus type 1 and 2, Varicella Zoster Virus, Treponema pallidum, and Monkeypox Virus.
Whole-workflow multi-analyte vaginal infection research use only (RUO) external quality controls are designed for nucleic acid amplification tests that detect the most common causes of vaginal infections, including bacterial vaginosis, vulvovaginal candidiasis, and trichomoniasis.
Gastrointestinal IVD Controls and RUO samples are available as single-analyte and multiplex liquid and swab formulations. The panel includes Cryptosporidium parvum, Giardia lamblia, Helicobacter pylori, C. difficile, Campylobacter, Rotavirus, and more.
Various ONBOARDx kits including RUO samples from our SARS-CoV-2, RESP and HPV EQC panels. Custom ONBOARDx™ kits to evaluate assay performance are also available.
Our Featured Infectious Disease Diagnostic Products
These featured products are whole workflow External Quality Controls that are formulated on Copan FLOQSwabs and inactivated to meet clinical laboratory biosafety requirements. Products are stable at ambient temperature for two years.
Purified Native Rubella Antigen
Featuring purified native rubella antigen free of detergent. Residual non-viral protein may come from host tissue and culture medium.
Delivering Global Excellence in Diagnostic Solutions
Microbix ships products to all seven continents and the majority of our IVD quality control products are CE marked, registered with the U.S. FDA, Australian TGA, U.K. and Health Canada establishment licensed.
Proudly Supporting Over 100+ Customers with Leading Diagnostic Solutions
Discover how customers leverage Microbix’s infectious disease diagnostics products to achieve greater success in accuracy, efficiency, and reliability.
We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality
Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.
We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
Alfie Zhen Fang, Buyer, Procurement
We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.
Robert Martinez, VP of Business Development & Scientific Affairs
MDx testing for HPV improves cervical cancer screening by identifying those at-risk efficiently. Close monitoring of the entire HPV testing workflow is critical to realizing this healthcare goal and Microbix’s HPV QAPs have been selected to support the quality assessment monitoring of the molecular testing process, a vital part of BVO’s quality management system
Dr. Rob Schuurman, National Reference Officer for the Dutch Cervical Cancer Screening Program (BVO)
r-Biopharm is pleased that the program will be delivering world-class diagnostic testing to some of the most remote populations in Australia. It has been a privilege to work with the program’s operational team and Microbix to integrate the use of the best possible test and test-workflow controls into the program
Andreas Simons, Director, Project Management Clinical Diagnostics
We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality
Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.
We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
Alfie Zhen Fang, Buyer, Procurement
We considered other external quality controls but selected Microbix QAPs as the best solution to support assay optimization and to significantly simplify QC procedures with minimal to no pipetting steps. Microbix’s technical expertise, product design, performance, and superior customer service are impressive. We look forward to continuing our collaboration.
Robert Martinez, VP of Business Development & Scientific Affairs
MDx testing for HPV improves cervical cancer screening by identifying those at-risk efficiently. Close monitoring of the entire HPV testing workflow is critical to realizing this healthcare goal and Microbix’s HPV QAPs have been selected to support the quality assessment monitoring of the molecular testing process, a vital part of BVO’s quality management system
Dr. Rob Schuurman, National Reference Officer for the Dutch Cervical Cancer Screening Program (BVO)
r-Biopharm is pleased that the program will be delivering world-class diagnostic testing to some of the most remote populations in Australia. It has been a privilege to work with the program’s operational team and Microbix to integrate the use of the best possible test and test-workflow controls into the program
Andreas Simons, Director, Project Management Clinical Diagnostics
We’re pleased to be employing Microbix’s innovative QAPs for this new and important EQA program. Genital ulcers are the cause of a considerable and growing burden of disease that can only be alleviated by way of accurate diagnosis and treatment
Juha Wahlstedt, Sales Director at Labquality
Microbix approached us before the pandemic started, and the relationship developed so easily and quickly that we formalized our collaboration in 2020. Along with their excellent technical capabilities, they have successfully developed relationships with many diagnostics manufacturers around the world. We are pleased that our FLOQSwabs® are their exclusive choice for their growing line of swab formatted QAPs™.
Gaetano Natale, Chief Commercial Officer.
We’ve been using Microbix’s External Quality controls for 3 years specifically from their Respiratory and Sexually Transmitted Infections panels on our instruments. It has helped us ensure accurate and reliable patient results and we’ve been delighted with their performance.
By choosing Microbix, you are aligning with a partner certified to the latest ISO standards and dedicated to delivering products that truly set the industry benchmark for quality.
Decades of Expertise
With over three decades of experience in the global diagnostics industry, Microbix has established a reputation as a leading infectious disease diagnostic manufacturer.
High-Risk HPV Quality Control for BD Onclarity™ Extended Genotyping
Performance of high-risk HPV single analyte and multiplex panel external quality controls for verification of extended genotyping on the BD Onclarity™ HPV Assay
Find a Microbix reseller near you and see how our global network supports businesses in enhancing their diagnostics operations with our innovative product lines.
Resellers Map:
CONTACT US
Secure Your Infectious Disease Diagnostic Controls
Let’s discuss how our infectious disease diagnostic solutions can support your research or diagnostics needs.